Arabic Translation and Validation of the (Overactive Bladder Symptom Score) OABSS

Validating 7-items Overactive Bladder Symptom Score (OABSS) Through Arabic Linguistic Version

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04309890

Enrollment

235

Registered

2020-03-16

Start date

2019-02-01

Completion date

2019-06-30

Last updated

2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive Bladder

Brief summary

The English version of the Overactive Bladder Symptom Score (OABSS) questionnaire was translated to Arabic language. The questionnaire was validated by comparing the response to the questionnaire in a patient with Overactive Bladder (OAB) before and after providing treatment with antimuscarinics.

Interventions

OTHERArabic version of the Overactive Bladder Symptom Score Questionnaire

All enrolled patients were asked to complete the Arabic OABSS questionnaire in its final edition before and three months after treatment with Solfinasin 5 mg once daily

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* More than 20 years * Had three months history of overactive bladder symptoms (urgency with or without incontinence and associated with frequency and nocturia).

Exclusion criteria

* Active urinary tract infection. * Predominant symptoms of urinary stress incontinence; * Diabetes mellitus; * Previous abdominal and pelvic (urological or gynecological gastrointestinal) surgery; * Previous neurological disease.

Design outcomes

Primary

Measure	Time frame
development and validation of Arabic version of the Overactive Bladder Symptom Score (OABSS) questionnaire	3 months

Countries

Jordan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026